The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the purine metabolism; meanwhile reactive oxygen species are formed. We hypothesized that uric acid production, as assessed indirectly from XOR variants, is associated with hypertension.status: publishe
Insulin resistance (IR) is a key component of metabolic syndrome (MetS). The pathogenesis of the syn...
Xanthine oxidoreductase (XOR) is an enzyme that catalyzes the two-step reaction from hypoxanthine to...
The enzyme xanthine oxidoreductase (XOR) catalyses the last step of purine degradation in the highes...
The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the purine met...
OBJECTIVE: The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the...
Objective: The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the...
Objectives Oxidative stress can modulate blood pressure levels in different models. Xanthine oxidore...
Uric acid levels are higher in humans than in other mammals. Best known as an extracellular antioxid...
none4si: Uric acid levels are higher in humans than in other mammals. Best known as an extracellular...
Abstract Xanthine oxidase (XO) is a metalloflavoenzyme associated with the uric acid formation in pu...
none3noThe relationship between serum uric acid (SUA) and hypertension has been a subject of increas...
Xanthine oxidoreductase (XOR) could contribute to the pathogenesis of metabolic syndrome through the...
Elevated serum uric acid concentration has been associated with high blood pressure (BP) and hyperte...
Cardiovascular diseases (CVD) are the leading cause of global mortality and their pathogenesis lies ...
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic disease ca...
Insulin resistance (IR) is a key component of metabolic syndrome (MetS). The pathogenesis of the syn...
Xanthine oxidoreductase (XOR) is an enzyme that catalyzes the two-step reaction from hypoxanthine to...
The enzyme xanthine oxidoreductase (XOR) catalyses the last step of purine degradation in the highes...
The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the purine met...
OBJECTIVE: The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the...
Objective: The enzyme xanthine oxidoreductase (XOR) generates uric acid in the terminal steps of the...
Objectives Oxidative stress can modulate blood pressure levels in different models. Xanthine oxidore...
Uric acid levels are higher in humans than in other mammals. Best known as an extracellular antioxid...
none4si: Uric acid levels are higher in humans than in other mammals. Best known as an extracellular...
Abstract Xanthine oxidase (XO) is a metalloflavoenzyme associated with the uric acid formation in pu...
none3noThe relationship between serum uric acid (SUA) and hypertension has been a subject of increas...
Xanthine oxidoreductase (XOR) could contribute to the pathogenesis of metabolic syndrome through the...
Elevated serum uric acid concentration has been associated with high blood pressure (BP) and hyperte...
Cardiovascular diseases (CVD) are the leading cause of global mortality and their pathogenesis lies ...
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic disease ca...
Insulin resistance (IR) is a key component of metabolic syndrome (MetS). The pathogenesis of the syn...
Xanthine oxidoreductase (XOR) is an enzyme that catalyzes the two-step reaction from hypoxanthine to...
The enzyme xanthine oxidoreductase (XOR) catalyses the last step of purine degradation in the highes...